Commentary: Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence - Top-Institutions - MDSpire

Analysis of Pemphigoid Linked to Quinolone Antibiotics: Insights from FDA Adverse Event Reports and Literature Review

  • By

  • Hai-Hong Lin

  • Kai-Li Mao

  • Liu-Cheng Li

  • Huan-Hao Zhou

  • July 17, 2026

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania (Penn Dermatology)
    University of Pennsylvania (Penn Dermatology)

    Philadelphia, Pennsylvania

    Key Differentiators

    • Dermatology
    • Autoimmune Blistering Diseases

  • #2

    Mayo Clinic (Department of Dermatology)
    Mayo Clinic (Department of Dermatology)

    Rochester, Minnesota

    Key Differentiators

    • Dermatology
    • Blistering Diseases

Original Source(s)

Commentary: Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence

  • by Hai-Hong Lin, Kai-Li Mao, Liu-Cheng Li, Huan-Hao Zhou

  • July 17, 2026

Related Content

Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations

Spatial mapping of Ethiopian cutaneous leishmaniasis lesions reveals distinct tissue level immune programs

Case Report: Treatment of trachyonychia in children with crisaborole: a retrospective case series